Pharmaceuticals, Biotechnology and Life Sciences
Primary Health Properties PLC, a UK-based investor in modern primary healthcare facilities, has appointed Geraldine Kennell and Nick Wiles to the Board as independent non-executive Directors.
The U.S. Treasury Department took new steps on Monday to curb tax-avoiding corporate “inversions,” with the pending $160 billion merger of Pfizer Inc and Allergan Plc seen as a potential casualty.
drugmaker Sanofi has poached one of AstraZeneca’s top scientists to be its new research head in another high-profile departure for the British drugmaker.
Skyepharma has made an application to the UK Listing Authority (UKLA) and the London Stock Exchange for the listing of 1,100,000…
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab…
Sanofi welcomes new Executive Committee member
Sanofi and MSD/Merck in joint vaccines operations in Europe
Premaitha signs distribution agreement with GeNext in Russia
Premaitha Health, the developer of IONA test, has partnered with Leeds Teaching Hospitals NHS Trust to provide a private NIPT…
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…